Colin Hill co-founded GNS Healthcare in 2000 and has served as its Chairman and CEO since that time.
Colin brings to the role impressive leadership experience and a solid track record of commercializing machine learning technology and precision medicine platforms in the biopharmaceutical and managed care industries.
In 2016, Colin was appointed to the board of directors of a leading publicly traded mobile health company that pioneered remote cardiac monitoring – Biotelemetry Inc. (formerly CardioNet) (NASDAQ: BEAT). He was appointed in 2015 by Massachusetts Governor Charlie Baker to the board of directors of the Center for Health Information and Analysis. He is also a founding board member of Transforming Medicine: The Elizabeth Kauffman Institute, a non-profit foundation (501c3) dedicated to the advancement of personalized medicine.
Colin was a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease (acquired by Baxter in 2014). He was the founding chairman of O’Reilly Media’s Strata Rx in 2012, the first healthcare big data conference in the industry. Colin also was the founding chairman of big data quantitative trading firm Fina Technologies and served from 2008 to 2011.
In 2004, Colin was named to the MIT Technology Review TR100 list of the top 100 innovators in the world under the age of 35. He is a frequent speaker at national and international scientific and industry conferences, including the annual meeting of America’s Health Insurance Plans (AHIP), the Pharmaceutical Research & Manufacturers of America (PhRMA) annual meeting, and the Forbes Healthcare Summit. Journalists and industry observers representing The Wall Street Journal, CNBC Morning Call and SquawkBox, Nature, The Boston Globe, Politico, Forbes, Wired, The Economist, Accenture, and Deloitte frequently turn to Colin as a valued resource for their research.
Colin graduated from Virginia Tech with a degree in physics and earned Master’s degrees in physics from both McGill University and Cornell University.